Cancer Cell. 2012 Jul 10;22(1):21-35. doi: 10.1016/j.ccr.2012.05.037.

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.

Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G.

Source

Department of Neurological Surgery, University of California, Helen Diller Family Cancer Research Center, San Francisco, CA 94143, USA.

Abstract

Inhibition of VEGF signaling leads to a proinvasive phenotype in mouse models of glioblastoma multiforme (GBM) and in a subset of GBM patients treated with bevacizumab. Here, we demonstrate that vascular endothelial growth factor (VEGF) directly and negatively regulates tumor cell invasion through enhanced recruitment of the protein tyrosine phosphatase 1B (PTP1B) to a MET/VEGFR2 heterocomplex, thereby suppressing HGF-dependent MET phosphorylation and tumor cell migration. Consequently, VEGF blockade restores and increases MET activity in GBM cells in a hypoxia-independent manner, while inducing a program reminiscent of epithelial-to-mesenchymal transition highlighted by a T-cadherin to N-cadherin switch and enhanced mesenchymal features. Inhibition of MET in GBM mouse models blocks mesenchymal transition and invasion provoked by VEGF ablation, resulting in substantial survival benefit.

Comment in

Migration: VEGF suppresses invasion. [Nat Rev Cancer. 2012]
Migration: VEGF suppresses invasion.McCarthy N. Nat Rev Cancer. 2012 Sep; 12(9):581. Epub 2012 Aug 2.
Receptor talk and tumor cell walk in glioblastoma. [Cancer Cell. 2012]
Receptor talk and tumor cell walk in glioblastoma.Claesson-Welsh L. Cancer Cell. 2012 Jul 10; 22(1):1-2.
RTK inhibition: looking for the right pathways toward a miracle. [Future Oncol. 2012]
RTK inhibition: looking for the right pathways toward a miracle.Xie Q, Vande Woude GF, Berens ME. Future Oncol. 2012 Nov; 8(11):1397-400.

PMID:: 22789536; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Brain Cancer - MedlinePlus Health Information

Miscellaneous

Supplemental Content

Save items

Related citations in PubMed

Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. [J Exp Med. 2012]
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.
Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova J, Lee M, Moudry P, Bartek J Jr, Fischer W, Lukas J, et al. J Exp Med. 2012 Mar 12; 209(3):507-20. Epub 2012 Mar 5.
Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. [Circ Res. 2008]
Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
Nakamura Y, Patrushev N, Inomata H, Mehta D, Urao N, Kim HW, Razvi M, Kini V, Mahadev K, Goldstein BJ, et al. Circ Res. 2008 May 23; 102(10):1182-91. Epub 2008 May 1.
17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion. [Oncol Rep. 2012]
17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
Miekus K, Kijowski J, Sekuła M, Majka M. Oncol Rep. 2012 Nov; 28(5):1903-9. Epub 2012 Aug 27.
Review Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review). [Int J Mol Med. 1999]
Review Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
Moriyama T, Kataoka H, Koono M, Wakisaka S. Int J Mol Med. 1999 May; 3(5):531-6.
Review Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. [Neuro Oncol. 2005]
Review Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
Abounader R, Laterra J. Neuro Oncol. 2005 Oct; 7(4):436-51.

See reviews... See all...

Cited by 8 PubMed Central articles

Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme. [Radiat Oncol. 2013]
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.
Shields LB, Kadner R, Vitaz TW, Spalding AC. Radiat Oncol. 2013 Apr 25; 8(1):101. Epub 2013 Apr 25.
Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. [Int J Hepatol. 2013]
Targeting the HGF-cMET Axis in Hepatocellular Carcinoma.
Venepalli NK, Goff L. Int J Hepatol. 2013; 2013:341636. Epub 2013 Mar 31.
Ionizing radiation in glioblastoma initiating cells. [Front Oncol. 2013]
Ionizing radiation in glioblastoma initiating cells.
Rivera M, Sukhdeo K, Yu J. Front Oncol. 2013; 3:74. Epub 2013 Apr 8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioSystems
Pathways and biological systems (BioSystems) that cite the current articles. Citations are from the BioSystems source databases (KEGG and BioCyc).
Gene
Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
Gene (GeneRIF)
Gene records that have the current articles as Reference into Function citations (GeneRIFs). NLM staff reviewing the literature while indexing MEDLINE add GeneRIFs manually.
HomoloGene
HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
MedGen
Related information in MedGen
Nucleotide (RefSeq)
NCBI nucleotide Reference Sequences (RefSeqs) that are cited in the current articles, included in the corresponding Gene Reference into Function, or that include the PubMed articles as references.
Nucleotide (Weighted)
Nucleotide records associated with the current articles through the Gene database. These are the related sequences on the Gene record that are added manually by NCBI.
Protein (RefSeq)
NCBI protein Reference Sequences (RefSeqs) that are cited in the current articles, included in the corresponding Gene Reference into Function, or that include the PubMed articles as references.
Protein (Weighted)
Protein records associated with the current articles through related Gene database records. These are the related sequences on the Gene record that are added manually by NCBI.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
UniGene
UniGene clusters of expressed sequences that are associated with the current articles through references on the clustered sequence records and related Gene records.
GEO Profiles
Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR...
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.
Cancer Cell. 2012 Jul 10 ;22(1):21-35. doi: 10.1016/j.ccr.2012.05.037.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: